MMP2 and angiomyolipoma: Except during cell motility, rapamycin had an inhibitory effect on the MMP-2 activity, without causing alteration in MMP-2 secretion and expression as previously described also in angiomyolipoma lacking-TSC2 cells and mouse embryonic cells that do not express Tsc1 or Tsc2 [22].